Pfizer Inc.

NYSE:PFE   3:59:58 PM EDT
44.18
-0.25 (-0.56%)
Regulatory, Other Pre-Announcement

Haleon H1 Adjusted Operating Profit Rose 21.2% To 1.191 Billion Stg

Published: 09/20/2022 06:43 GMT
Pfizer Inc. (PFE) - Haleon Plc - 2022 Half Year Results.
Haleon Plc - 2022 Half Year Results.
Haleon Plc H1 Revenue Rose 13.4 Percent to 5.188 Billion Stg.
Haleon Plc H1 Adjusted Operating Profit Rose 21.2 Percent to 1.191 Billion Stg.
Haleon Plc H1 Adjusted Operating Profit Rose 21.2 Percent to 1.191 Billion Stg.
Haleon Plc - FY22 Organic Revenue Growth and Adjusted Operating Margin Guidance Unchanged.
Haleon Plc - Positive Momentum Seen in First Half of Year Has Continued Into Q3, Albeit at a Slower Rate As Expected.
Haleon Plc - Whilst Navigating Current Macro-economic Challenges and Uncertainties, Positive Momentum in Our Business Has Continued Into Second Half.
Haleon: on Zantac Says Notified Gsk, Pfizer It Rejects Their Requests for Indemnification.